Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease

Transfusion

Volumn 52, Issue 2, 2012, Pages 381-388

  Wilkinson, Katie ^a   Harris, Samantha ^a   Gaur, Prashant ^a   Haile, Askale ^a   Armour, Rosalind ^a   Teramura, Gayle ^a   Delaney, Meghan ^a  

^a PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIGEN; GENOMIC DNA;

ARTICLE; BLOOD DONOR; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CAUCASIAN; ERYTHROCYTE; GENE MUTATION; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; MOLECULAR GENETICS; PHENOTYPE; PROMOTER REGION; SEROLOGY; SICKLE CELL ANEMIA;

ADULT; ALGORITHMS; ANEMIA, SICKLE CELL; BLOOD DONORS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTE TRANSFUSION; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULAR TYPING; PREVALENCE; SEROLOGIC TESTS; UP-REGULATION; YOUNG ADULT;

EID: 84855841711     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03288.x     Document Type: Article

References (33)

1. National Center for Biotechnology Information (NCBI, US). Genes and disease. Bethesda (MD): National Center for Biotechnology Information (US); 1998-2010.
2. Stuart MJ, Nagel RL,. Sickle-cell disease. Lancet 2004; 364: 1343-60. (Pubitemid 39335827)
3. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D,. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med 1998; 339: 5-11. (Pubitemid 28304491)
4. Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ, Stroke Prevention Trail in Sickle Cell Anemia. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41: 1086-92. (Pubitemid 32848083)
5. Hankins JS, Smeltzer MP, McCarville MB, Aygun B, Hillenbrand CM, Ware RE, Onciu M,. Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload. Eur J Haematol 2010; 85: 51-7.
6. Danielson CF,. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002; 6: 24-31. (Pubitemid 34218724)
7. Swerdlow PS,. Red cell exchange in sickle cell disease. Hematology Am Soc Hematol Educ Program 2006; 48-53.
8. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V,. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002; 42: 37-43.
9. Godfrey GJ, Lockwood W, Kong M, Bertolone S, Raj A,. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis. Pediatr Blood Cancer 2010; 55: 1134-7.
10. Hashmi G, Shariff T, Zhang Y, Cristobal J, Chau C, Seul M, Vissavajjhala P, Baldwin C, Hue-Roye K, Charles-Pierre D, Lomas-Francis C, Reid ME,. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007; 47: 736-47. (Pubitemid 46449636)
11. Daniels G,. Human blood groups. 2nd ed. Oxford, UK: Blackwell Science; 2002.
12. Chou ST, Westhoff CM,. Molecular biology of the rh system: clinical considerations for transfusion in sickle cell disease. Hematology Am Soc Hematol Educ Program 2009; 178-84.
13. Osby M, Shulman IA,. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 north american laboratories. Arch Pathol Lab Med 2005; 129: 190-3. (Pubitemid 40204796)
14. Afenyi-Annan A, Brecher ME,. Pre-transfusion phenotype matching for sickle cell disease patients. Transfusion 2004; 44: 619-20. (Pubitemid 38437601)
15. Rouillac C, Colin Y, Hughes-Jones NC, Beolet M, D'Ambrosio AM, Cartron JP, Le Van Kim C,. Transcript analysis of D category phenotypes predicts hybrid rh D-CE-D proteins associated with alteration of D epitopes. Blood 1995; 85: 2937-44.
16. International Society for Blood Transfusion. Draft terminology for blood group alleles. 2010 [cited 2010 Oct 22]. Available from: URL
17. Westhoff CM, Vege S, Halter-Hipsky C, Whorley T, Hue-Roye K, Lomas-Francis C, Reid ME,. DIIIa and DIII type 5 are encoded by the same allele and are associated with altered RHCE ce alleles: clinical implications. Transfusion 2010; 50: 1303-11.
18. Meny GM,. The duffy blood group system: a review. Immunohematology 2010; 26: 51-6.
19. Castilho L,. The value of DNA analysis for antigens in the duffy blood group system. Transfusion 2007; 1 (Suppl): 28S-31S. (Pubitemid 46934291)
20. Cox JV, Steane E, Cunningham G, Frenkel EP,. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988; 148: 2485-9.
21. Lasalle-Williams M, Nuss R, Le T, Cole L, Hassell K, Murphy JR, Ambruso DR,. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center. Transfusion 2011; 51: 1732-9.
22. Ambruso DR, Githens JH, Alcorn R, Dixon DJ, Brown LJ, Vaughn WM, Hays T,. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987; 27: 94-8. (Pubitemid 17030045)
23. Castro O, Sandler SG, Houston-Yu P, Rana S,. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002; 42: 684-90.
24. Davies SC, McWilliam AC, Hewitt PE, Devenish A, Brozovic M,. Red cell alloimmunization in sickle cell disease. Br J Haematol 1986; 63: 241-5. (Pubitemid 16085856)
25. Sakhalkar VS, Roberts K, Hawthorne LM, McCaskill DM, Veillon DM, Caldito GC, Cotelingam JD,. Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci 2005; 1054: 495-9. (Pubitemid 43031064)
26. Klapper E, Zhang Y, Figueroa P, Ness P, Stubbs J, Abumuhor I, Bailey J, Epperson L, Tauscher C, Enriquez E, Hashmi G, Seul M,. Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 2010; 50: 536-46.
27. Murphy EL, Shaz B, Hillyer CD, Carey P, Custer BS, Hirschler N, Fang J, Schreiber GB, NHLBI Retrovirus Epidemiology in Blood Donors Study-II (REDS-II). Minority and foreign-born representation among US blood donors: demographics and donation frequency for. Transfusion 2006; 49: 2221-8.
28. U.S. Census Bureau. US census report: the 2009 statistical abstract. 2009. [cited 2009 Aug 1]. Available from: URL
29. Le Pennec PY, Rouger P, Klein MT, Robert N, Salmon C,. Study of anti-fya in five black fy(a-b-) patients. Vox Sang 1987; 52: 246-9. (Pubitemid 17064549)
30. Westhoff CM,. The structure and function of the rh antigen complex. Semin Hematol 2007; 44: 42-50. (Pubitemid 46013923)
31. Aygun B, McMurray MA, Schultz WH, Kwiatkowski JL, Hilliard L, Alvarez O, Heeney M, Kalinyak K, Lee MT, Miller S, Helms RW, Ware RE, SWiTCH Trial Investigators. Chronic transfusion practice for children with sickle cell anaemia and stroke. Br J Haematol 2009; 145: 524-8.
32. Schwickerath V, Kowalski M, Menitove JE,. Regional registry of patient alloantibodies: first-year experience. Transfusion 2010; 50: 1465-70.
33. Higgins JM, Sloan SR,. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008; 112: 2546-53.